ELI LILLY AND COMPAN

LLY
Real-time Estimate Quote. Real-time Estimate  - 08/05 03:49:17 pm
153.825USD -0.66%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (47.6%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (17.4%);
- veterinary medicine (12.8%);
- cardiovascular diseases (9.2%);
- neurology (7.4%): primarily drugs used in treating depression and schizophrenia;
- immunology diseases (4.6%);
- other (1%).
Net sales are distributed geographically as follows: the United States (56.5%), Europe (17.2%), Japan (10.2%) and other (16.1%).

Number of employees : 33 625 people.
Sales per Business
2019
USD
(in Million)
%
Pharmaceutical Products 22,320100%
Sales per region
20182019
USD
(in Million)
%USD
(in Million)
%
United States 13,87556.5% 12,72357%
Europe 4,23117.2% 3,76516.9%
Other Foreign Countries 3,95616.1% 3,28414.7%
Japan 2,49410.2% 2,54811.4%
Managers
Name Title
David A. Ricks Chairman, President & Chief Executive Officer
Joshua L. Smiley Chief Financial Officer & Senior Vice President
Timothy J. Garnett Chief Medical Officer & VP-Global Medical
Aarti S. Shah Chief Information & Digital Officer, Senior VP
Daniel M. Skovronsky Chief Scientific Officer & Senior Vice President
Kathi P. Seifert Independent Director
Jon Erik Fyrwald Independent Director
Michael L. Eskew Independent Director
Ralph Alvarez Independent Director
Katherine Baicker Independent Director
Shareholders
Name Equities %
Lilly Endowment, Inc. 111,132,343 11.6%
Capital Research & Management Co. 109,033,091 11.4%
The Vanguard Group, Inc. 68,455,693 7.15%
PRIMECAP Management Co. 41,935,302 4.38%
SSgA Funds Management, Inc. 37,051,162 3.87%
Wellington Management Co. LLP 36,023,507 3.76%
Fidelity Management & Research Co. LLC 26,499,308 2.77%
Capital Research & Management Co. (International Investors) 22,776,795 2.38%
BlackRock Fund Advisors 20,833,863 2.18%
State Farm Investment Management Corp. 18,619,725 1.95%
Company contact information
Lilly Corporate Center
IN 46285 Indianapolis, Indiana
États-Unis (les)

Phone : +1 617-225-3226
Fax : +1
Internet : https://investor.lilly.com/
Markets and indexes
- NYSE
- Main Market
- SP 100 / SP 500, Stoxx Americas 100, Stoxx Global 200
Stock Exchange Codes
- Bloomberg Code :  LLY:US
- Reuters Code :  LLY.N
Sector Pharmaceuticals - NEC
1st jan.Capi. (M$)
ELI LILLY AND COMPANY17.82%140 367
JOHNSON & JOHNSON0.93%387 604
ROCHE HOLDING AG2.26%299 665
PFIZER, INC.-2.02%213 250
MERCK & CO., INC.-10.20%206 143
NOVARTIS AG-16.12%185 541
ABBVIE INC.6.49%166 171
NOVO NORDISK A/S6.10%151 044
ASTRAZENECA PLC12.40%146 534
AMGEN INC.1.05%142 669
BRISTOL-MYERS SQUIBB COMPANY-7.35%134 562
SANOFI-1.57%130 441
GLAXOSMITHKLINE PLC-11.58%102 242
CHUGAI PHARMACEUTICAL CO., LTD.46.61%76 269
JIANGSU HENGRUI MEDICINE CO., LTD.27.23%71 217
BAYER AG-21.65%65 969
ALLERGAN PLC0.97%63 659
TAKEDA PHARMACEUTICAL COMPANY LIMITED-9.79%57 602
DAIICHI SANKYO COMPANY, LIMITED27.02%55 849
ASTELLAS PHARMA INC.-9.12%29 980
CHANGCHUN HIGH & NEW TECHNOLOGY INDUSTRY (GROUP) INC.123.26%29 024
Brand Portfolio
ARMO BIOSCIENCES
ARMO BIOSCIENCES
CHEMGEN
CHEMGEN
ELI LILLY AND COMPANY
ELI LILLY AND COMPANY
IMCLONE SYSTEMS
IMCLONE SYSTEMS
LOXO ONCOLOGY
LOXO ONCOLOGY
PHARMASERVE-LILLY
PHARMASERVE-LILLY
» More brands of Eli Lilly And Company